Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Attention/vigilance in schizophrenia: performance results from a large multi-site study of the Consortium on the Genetics of Schizophrenia (COGS).

Nuechterlein KH, Green MF, Calkins ME, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Sprock J, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL.

Schizophr Res. 2015 Apr;163(1-3):38-46. doi: 10.1016/j.schres.2015.01.017. Epub 2015 Mar 4.

2.

Assessing long-term test-retest reliability of the CPT-IP in schizophrenia.

Hahn E, Vollath A, Ta TT, Hahn C, Kuehl LK, Dettling M, Neuhaus AH.

PLoS One. 2014 Jan 8;9(1):e84780. doi: 10.1371/journal.pone.0084780. eCollection 2014.

3.

Association of a Serotonin Receptor 2A Gene Polymorphism with Visual Sustained Attention in Early-Onset Schizophrenia Patients and their Non-Psychotic Siblings.

Vyas NS, Lee Y, Ahn K, Ternouth A, Stahl DR, Al-Chalabi A, Powell JF, Puri BK.

Aging Dis. 2012 Aug;3(4):291-300. Epub 2012 Jun 30.

4.

A developmental look at the attentional system in the at risk and first episode of psychosis: age related changes in attention along the psychosis spectrum.

Mirzakhanian H, Singh F, Seeber K, Shafer KM, Cadenhead KS.

Cogn Neuropsychiatry. 2013;18(1-2):26-43. doi: 10.1080/13546805.2012.713770. Epub 2012 Sep 21.

5.

Markers of vulnerability in schizophrenia.

Ladea M, Prelipceanu D.

J Med Life. 2009 Apr-Jun;2(2):155-64. Review.

6.

Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.

Correll CU, Smith CW, Auther AM, McLaughlin D, Shah M, Foley C, Olsen R, Lencz T, Kane JM, Cornblatt BA.

J Child Adolesc Psychopharmacol. 2008 Oct;18(5):475-90. doi: 10.1089/cap.2007.110.

7.

Affective traits in schizophrenia and schizotypy.

Horan WP, Blanchard JJ, Clark LA, Green MF.

Schizophr Bull. 2008 Sep;34(5):856-74. doi: 10.1093/schbul/sbn083. Epub 2008 Jul 29. Review.

8.

The Consortium on the Genetics of Schizophrenia: neurocognitive endophenotypes.

Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS.

Schizophr Bull. 2007 Jan;33(1):49-68. Epub 2006 Nov 13. Review.

9.

Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis.

Brewer WJ, Wood SJ, Phillips LJ, Francey SM, Pantelis C, Yung AR, Cornblatt B, McGorry PD.

Schizophr Bull. 2006 Jul;32(3):538-55. Epub 2006 Jun 16. Review.

10.

Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies.

Seidman LJ, Giuliano AJ, Smith CW, Stone WS, Glatt SJ, Meyer E, Faraone SV, Tsuang MT, Cornblatt B.

Schizophr Bull. 2006 Jul;32(3):507-24. Epub 2006 May 17.

11.

A review of emotion deficits in schizophrenia.

Trémeau F.

Dialogues Clin Neurosci. 2006;8(1):59-70. Review.

12.

The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia.

Braff DL, Light GA.

Dialogues Clin Neurosci. 2005;7(2):125-35. Review.

13.

Anhedonia in schizophrenia: a review of assessment strategies.

Horan WP, Kring AM, Blanchard JJ.

Schizophr Bull. 2006 Apr;32(2):259-73. Epub 2005 Oct 12. Review.

Supplemental Content

Support Center